Patients claim that, instead of leaving the body quickly after use, the gadolinium dye has stayed in their bodies for months or even years afterward, leading to further problems. They’re now suing 11 separate makers of these contrast dyes in a $10 million lawsuit. Since the late 1980s, gadolinium has been used in some contrast dyes because of its strong paramagnetic properties, which react to the magnetic resona… During an MRI scan, a gadolinium contrast dye is often injected intravenously to enhance the imaging of the scan. What is Gadolinium Contrast Dye? By Jane Mundy: Health Canada says gadolinium, the contrast agent used in MRI imaging, can build up in the brain, but won’t call it harmful. An Arizona woman has filed a new lawsuit, alleging that the gadolinium contrast dye used during her MRI scan stayed in her body long after the scan was... Read More, © 2020 Top Class Actions LLC. A new MRI contrast dye lawsuit claims gadolinium retention from Optimark and Multihance caused an Arizona woman to suffer severe injuries, including fibrosis in her organs, bones, and skin. The complaint was filed in San Francisco on May 28, 2019. Gadolinium Lawsuit. are no longer reviewing additional Gadolinium MRI Contrast lawsuits. A review has found that low levels of gadolinium can be retained in the brain and other tissues after administration of gadolinium-containing contrast agents (GdCAs). While gadolinium-based contrast agents (GBCAs) have long been recognized as critical components of MRI, the pharmacokinetics, pharmacodynamics and potential toxicity of these agents are under increasing scrutiny, particularly with reports that gadolinium can accumulate in the brain after contrast enhanced MRI examinations. July 25, 2018 - The FDA approved an updated label for Magnevist, a type of contrast agent. The Gadolinium in Humans paper from the American Journal of Radiology is included in the lawsuit filed in San Francisco. February 24, 2019 – Researchers from Finland, led by Dr. Aida Kiviniemi, found that gadolinium deposits can be detected in both enhancing and non-enhancing gliomas, adjacent normal brain tissue, and necrosis. Friday, May 10, 2019: FDA Approved Magnevist Alleged For Multiple Organ Damages. If you or a loved one developed gadolinium toxicity after having an MRI with gadolinium contrast, you may be eligible to file a gadolinium MRI lawsuit against pharmaceutical companies. Despite being marketed for decades as a safe product, this substance has been recently found to be associated with severe toxicity.
The Gadolinium Deposition Disease Lawsuit alleges that: Gena Norris received Gadolinium intravenously during her MRI scan. Currently there is only thing that partly helps in chelating gadolinium and that is CA/ZN DTPA IV. At least one-third of MRI (Magnetic Resonance Imaging) scans are performed with a contrast agent known as Gadolinium to enhance the quality of the image. Gadolinium is a heavy-white metal that is used in contrast dyes for clearer imaging when using an MRI and other imaging systems.
Gadolinium MRI contrast agents have been linked to a rare disease. Think Again In Alternative Cancer Therapies, Breast Cancer, Cancer, Gadolinium, MRI Dangers, Uncategorized on October 7, 2019 at 8:31 am Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis. Please note that if you select "No," you may not qualify for this investigation. Friday, May 24, 2019: Lawsuits Allege Gadolinium For Its Health Risks. General safety issues 6 4. Gadolinium lawsuit settlements may be available.